Progyny, Inc. (PGNY)

Market Cap	1.48B
Revenue (ttm)	1.13B
Net Income (ttm)	62.75M
Shares Out	90.28M
EPS (ttm)	0.63
PE Ratio	25.96
Forward PE	10.36
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,699,187
Open	16.92
Previous Close	16.85
Day's Range	16.32 - 17.02
52-Week Range	13.93 - 42.08
Beta	1.43
Analysts	Buy
Price Target	22.67 (+38.65%)
Earnings Date	Nov 5, 2024

About PGNY

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various servic...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Oct 25, 2019
• Employees: 566
• Stock Exchange: NASDAQ
• Ticker Symbol: PGNY
• Website: https://www.progyny.com

Financial Performance

In 2023, Progyny's revenue was $1.09 billion, an increase of 38.34% compared to the previous year's $786.91 million. Earnings were $62.04 million, an increase of 104.35%.

Analyst Forecast

According to 9 analysts, the average rating for PGNY stock is "Buy." The 12-month stock price forecast is $22.67, which is an increase of 38.65% from the latest price.

Price Target

$22.67

(38.65% upside)

Analyst Consensus: Buy